PyIgClassify2: Canonical Clusters of Antibody CDR Loop Conformations

PyIgClassify2: Classification of Antibody CDR Conformations

CDRs for query 3UTZ

#CDRs = 8; #Clusters = 10.
Chain	Gene	PDB Species	Frame Germline	Frame %	CDR Germline	CDR %	CDR	Length	Cluster	Distance(°)	Sequence	Ramachandran
A	kappa	Mus.musculus	Mo_IGKV1-117*01	100.0	Mo_IGKV1-117*01	93.8	L1	16	L1-16-*	-1	RSSQSIvhsngNTFLE	BBABBABBBAEBBBBB
A	kappa	Mus.musculus	Mo_IGKV1-117*01	100.0	Mo_IGKV1-117*01	100.0	L2	8	L2-8-1	7	YKVSNRFS	BLEABBBB
A	kappa	Mus.musculus	Mo_IGKV1-117*01	100.0	Mo_IGKV1-117*01	85.7	L3	9	L3-9-cis7-1	13	FQASHVPPT	BBAABBbBB
A	kappa	Mus.musculus	Mo_IGKV1-117*01	100.0	Mo_IGKV1-117*01	100.0	L4	6	L4-6-1	21	GSGTDF	EBEABB
B	heavy	Mus.musculus	Mo_IGHV5-9*02	95.9	Mo_IGHV5-9*02	92.3	H1	13	H1-13-1	10	AASGFAFSTYDMS	BBBLBBAAABBBB
B	heavy	Mus.musculus	Mo_IGHV5-9*02	95.9	Mo_IGHV5-9*02	100.0	H2	10	H2-10-2	9	TISSGGSYTY	BBBAALABBB
B	heavy	Mus.musculus	Mo_IGHV5-9*02	95.9	Mo_IGHV5-9*02	50.0	H3	12	H3-12-*	-1	TRFRYDGWYFDV	BBBBABLLBBAB
B	heavy	Mus.musculus	Mo_IGHV5-9*02	95.9	Mo_IGHV5-9*02	87.5	H4	8	H4-8-1	7	KDNARNTL	BBAAALBB
C	heavy	Mus.musculus	Mo_IGHV5-9*02	95.9	Mo_IGHV5-9*02	92.3	H1	13	H1-13-1	9	AASGFAFSTYDMS	BBBLBBAAABBBB
C	heavy	Mus.musculus	Mo_IGHV5-9*02	95.9	Mo_IGHV5-9*02	100.0	H2	10	H2-10-*	-1	TISSGGsYTY
C	heavy	Mus.musculus	Mo_IGHV5-9*02	95.9	Mo_IGHV5-9*02	50.0	H3	12	H3-12-*	-1	TRFRYDGWYFDV	BBBBABLLBBAB
C	heavy	Mus.musculus	Mo_IGHV5-9*02	95.9	Mo_IGHV5-9*02	87.5	H4	8	H4-8-1	10	KDNARNTL	BBAAALBB
D	kappa	Mus.musculus	Mo_IGKV1-117*01	100.0	Mo_IGKV1-117*01	93.8	L1	16	L1-16-*	-1	RSSQSIvhsngNTFLE
D	kappa	Mus.musculus	Mo_IGKV1-117*01	100.0	Mo_IGKV1-117*01	100.0	L2	8	L2-8-1	8	YKVSNRFS	BLEABBBB
D	kappa	Mus.musculus	Mo_IGKV1-117*01	100.0	Mo_IGKV1-117*01	85.7	L3	9	L3-9-cis7-1	12	FQASHVPPT	BBAABBbBB
D	kappa	Mus.musculus	Mo_IGKV1-117*01	100.0	Mo_IGKV1-117*01	100.0	L4	6	L4-6-1	18	GSGTDF	EBEABB
E	kappa	Mus.musculus	Mo_IGKV1-117*01	100.0	Mo_IGKV1-117*01	93.8	L1	16	L1-16-*	-1	RSSQSIvhsngNTFLE
E	kappa	Mus.musculus	Mo_IGKV1-117*01	100.0	Mo_IGKV1-117*01	100.0	L2	8	L2-8-1	7	YKVSNRFS	BLLABBBB
E	kappa	Mus.musculus	Mo_IGKV1-117*01	100.0	Mo_IGKV1-117*01	85.7	L3	9	L3-9-cis7-1	10	FQASHVPPT	BBAABBbBB
E	kappa	Mus.musculus	Mo_IGKV1-117*01	100.0	Mo_IGKV1-117*01	100.0	L4	6	L4-6-*	-1	GsGTDF
F	heavy	Mus.musculus	Mo_IGHV5-9*02	95.9	Mo_IGHV5-9*02	92.3	H1	13	H1-13-1	11	AASGFAFSTYDMS	BBBLBBAAABBBB
F	heavy	Mus.musculus	Mo_IGHV5-9*02	95.9	Mo_IGHV5-9*02	100.0	H2	10	H2-10-2	6	TISSGGSYTY	BBBAALABBB
F	heavy	Mus.musculus	Mo_IGHV5-9*02	95.9	Mo_IGHV5-9*02	50.0	H3	12	H3-12-*	-1	TRFRYDGWYFDV	BBBBABLLBBAB
F	heavy	Mus.musculus	Mo_IGHV5-9*02	95.9	Mo_IGHV5-9*02	87.5	H4	8	H4-8-1	7	KDNARNTL	BBAAALBB

Site developed by the Antibody Team at the lab of Roland Dunbrack. Last updated on Oct. 13, 2022